| Vesna Tegeltija, MD | |
|
1101 W University Dr, 3-north, Rochester, MI 48307-1863 | |
| (248) 601-4805 | |
| (248) 601-4908 |
| Full Name | Vesna Tegeltija |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 12 Years |
| Location | 1101 W University Dr, Rochester, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538504956 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 4301103378 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension Providence - Crittenton Hospital Medical Center | Rochester, MI | Hospital |
| Ascension St John Hospital | Detroit, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Independent Hospitalist Physicians Pllc | 3971874090 | 43 |
| Ascension Providence Rochester Hospital | 8820994098 | 88 |
News Archive
Designed with the complete workflow in mind, Olympus has launched its cellVivo incubation system, for precise and ergonomic environmental control of advanced live cell imaging. Following the modular approach of the IX3 range of inverted microscope frames, cellVivo is based on a "one size fits all" concept, with adaptors for various IX73 and IX83 frame types, circumventing the need for multiple incubation systems for distinct microscope configurations.
Researchers from Texas A&M University, led by Dr. Akhilesh K. Gaharwar, have developed a new way to deliver treatment for cartilage regeneration.
Dune Medical Devices, Inc. today announced that the landmark, 664-patient pivotal trial evaluating the MarginProbe System met its primary endpoints. The MarginProbe System provides surgeons with a real time, intraoperative technology to detect microscopically-positive margins on excised tissues.
Laquinimod is an orally available synthetic compound that has been successfully evaluated in phase II/III clinical studies for the treatment of relapsing-remitting multiple sclerosis (RRMS).
"The effectiveness of an experimental malaria vaccine developed by GlaxoSmithKline wanes over time, with the shot protecting only 16.8 percent of children over four years, according to trial data," Reuters reports.
› Verified 7 days ago
| Entity Name | Rochester Urgent Care, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316018971 PECOS PAC ID: 2264334564 Enrollment ID: O20040127000012 |
News Archive
Designed with the complete workflow in mind, Olympus has launched its cellVivo incubation system, for precise and ergonomic environmental control of advanced live cell imaging. Following the modular approach of the IX3 range of inverted microscope frames, cellVivo is based on a "one size fits all" concept, with adaptors for various IX73 and IX83 frame types, circumventing the need for multiple incubation systems for distinct microscope configurations.
Researchers from Texas A&M University, led by Dr. Akhilesh K. Gaharwar, have developed a new way to deliver treatment for cartilage regeneration.
Dune Medical Devices, Inc. today announced that the landmark, 664-patient pivotal trial evaluating the MarginProbe System met its primary endpoints. The MarginProbe System provides surgeons with a real time, intraoperative technology to detect microscopically-positive margins on excised tissues.
Laquinimod is an orally available synthetic compound that has been successfully evaluated in phase II/III clinical studies for the treatment of relapsing-remitting multiple sclerosis (RRMS).
"The effectiveness of an experimental malaria vaccine developed by GlaxoSmithKline wanes over time, with the shot protecting only 16.8 percent of children over four years, according to trial data," Reuters reports.
› Verified 7 days ago
| Entity Name | Lakeside Urgent Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720159304 PECOS PAC ID: 0446146385 Enrollment ID: O20040226000404 |
News Archive
Designed with the complete workflow in mind, Olympus has launched its cellVivo incubation system, for precise and ergonomic environmental control of advanced live cell imaging. Following the modular approach of the IX3 range of inverted microscope frames, cellVivo is based on a "one size fits all" concept, with adaptors for various IX73 and IX83 frame types, circumventing the need for multiple incubation systems for distinct microscope configurations.
Researchers from Texas A&M University, led by Dr. Akhilesh K. Gaharwar, have developed a new way to deliver treatment for cartilage regeneration.
Dune Medical Devices, Inc. today announced that the landmark, 664-patient pivotal trial evaluating the MarginProbe System met its primary endpoints. The MarginProbe System provides surgeons with a real time, intraoperative technology to detect microscopically-positive margins on excised tissues.
Laquinimod is an orally available synthetic compound that has been successfully evaluated in phase II/III clinical studies for the treatment of relapsing-remitting multiple sclerosis (RRMS).
"The effectiveness of an experimental malaria vaccine developed by GlaxoSmithKline wanes over time, with the shot protecting only 16.8 percent of children over four years, according to trial data," Reuters reports.
› Verified 7 days ago
| Entity Name | University Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447299797 PECOS PAC ID: 8628087681 Enrollment ID: O20060419000518 |
News Archive
Designed with the complete workflow in mind, Olympus has launched its cellVivo incubation system, for precise and ergonomic environmental control of advanced live cell imaging. Following the modular approach of the IX3 range of inverted microscope frames, cellVivo is based on a "one size fits all" concept, with adaptors for various IX73 and IX83 frame types, circumventing the need for multiple incubation systems for distinct microscope configurations.
Researchers from Texas A&M University, led by Dr. Akhilesh K. Gaharwar, have developed a new way to deliver treatment for cartilage regeneration.
Dune Medical Devices, Inc. today announced that the landmark, 664-patient pivotal trial evaluating the MarginProbe System met its primary endpoints. The MarginProbe System provides surgeons with a real time, intraoperative technology to detect microscopically-positive margins on excised tissues.
Laquinimod is an orally available synthetic compound that has been successfully evaluated in phase II/III clinical studies for the treatment of relapsing-remitting multiple sclerosis (RRMS).
"The effectiveness of an experimental malaria vaccine developed by GlaxoSmithKline wanes over time, with the shot protecting only 16.8 percent of children over four years, according to trial data," Reuters reports.
› Verified 7 days ago
| Entity Name | Ascension Providence Rochester Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366565442 PECOS PAC ID: 8820994098 Enrollment ID: O20071117000068 |
News Archive
Designed with the complete workflow in mind, Olympus has launched its cellVivo incubation system, for precise and ergonomic environmental control of advanced live cell imaging. Following the modular approach of the IX3 range of inverted microscope frames, cellVivo is based on a "one size fits all" concept, with adaptors for various IX73 and IX83 frame types, circumventing the need for multiple incubation systems for distinct microscope configurations.
Researchers from Texas A&M University, led by Dr. Akhilesh K. Gaharwar, have developed a new way to deliver treatment for cartilage regeneration.
Dune Medical Devices, Inc. today announced that the landmark, 664-patient pivotal trial evaluating the MarginProbe System met its primary endpoints. The MarginProbe System provides surgeons with a real time, intraoperative technology to detect microscopically-positive margins on excised tissues.
Laquinimod is an orally available synthetic compound that has been successfully evaluated in phase II/III clinical studies for the treatment of relapsing-remitting multiple sclerosis (RRMS).
"The effectiveness of an experimental malaria vaccine developed by GlaxoSmithKline wanes over time, with the shot protecting only 16.8 percent of children over four years, according to trial data," Reuters reports.
› Verified 7 days ago
| Entity Name | Oxford Urgent Care P L C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700036936 PECOS PAC ID: 7214094291 Enrollment ID: O20090318000322 |
News Archive
Designed with the complete workflow in mind, Olympus has launched its cellVivo incubation system, for precise and ergonomic environmental control of advanced live cell imaging. Following the modular approach of the IX3 range of inverted microscope frames, cellVivo is based on a "one size fits all" concept, with adaptors for various IX73 and IX83 frame types, circumventing the need for multiple incubation systems for distinct microscope configurations.
Researchers from Texas A&M University, led by Dr. Akhilesh K. Gaharwar, have developed a new way to deliver treatment for cartilage regeneration.
Dune Medical Devices, Inc. today announced that the landmark, 664-patient pivotal trial evaluating the MarginProbe System met its primary endpoints. The MarginProbe System provides surgeons with a real time, intraoperative technology to detect microscopically-positive margins on excised tissues.
Laquinimod is an orally available synthetic compound that has been successfully evaluated in phase II/III clinical studies for the treatment of relapsing-remitting multiple sclerosis (RRMS).
"The effectiveness of an experimental malaria vaccine developed by GlaxoSmithKline wanes over time, with the shot protecting only 16.8 percent of children over four years, according to trial data," Reuters reports.
› Verified 7 days ago
| Entity Name | Washington Urgent Care Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891045563 PECOS PAC ID: 4981857489 Enrollment ID: O20130112000065 |
News Archive
Designed with the complete workflow in mind, Olympus has launched its cellVivo incubation system, for precise and ergonomic environmental control of advanced live cell imaging. Following the modular approach of the IX3 range of inverted microscope frames, cellVivo is based on a "one size fits all" concept, with adaptors for various IX73 and IX83 frame types, circumventing the need for multiple incubation systems for distinct microscope configurations.
Researchers from Texas A&M University, led by Dr. Akhilesh K. Gaharwar, have developed a new way to deliver treatment for cartilage regeneration.
Dune Medical Devices, Inc. today announced that the landmark, 664-patient pivotal trial evaluating the MarginProbe System met its primary endpoints. The MarginProbe System provides surgeons with a real time, intraoperative technology to detect microscopically-positive margins on excised tissues.
Laquinimod is an orally available synthetic compound that has been successfully evaluated in phase II/III clinical studies for the treatment of relapsing-remitting multiple sclerosis (RRMS).
"The effectiveness of an experimental malaria vaccine developed by GlaxoSmithKline wanes over time, with the shot protecting only 16.8 percent of children over four years, according to trial data," Reuters reports.
› Verified 7 days ago
| Entity Name | Elizabeth Lake Urgent Care Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538585260 PECOS PAC ID: 3375769078 Enrollment ID: O20140731002302 |
News Archive
Designed with the complete workflow in mind, Olympus has launched its cellVivo incubation system, for precise and ergonomic environmental control of advanced live cell imaging. Following the modular approach of the IX3 range of inverted microscope frames, cellVivo is based on a "one size fits all" concept, with adaptors for various IX73 and IX83 frame types, circumventing the need for multiple incubation systems for distinct microscope configurations.
Researchers from Texas A&M University, led by Dr. Akhilesh K. Gaharwar, have developed a new way to deliver treatment for cartilage regeneration.
Dune Medical Devices, Inc. today announced that the landmark, 664-patient pivotal trial evaluating the MarginProbe System met its primary endpoints. The MarginProbe System provides surgeons with a real time, intraoperative technology to detect microscopically-positive margins on excised tissues.
Laquinimod is an orally available synthetic compound that has been successfully evaluated in phase II/III clinical studies for the treatment of relapsing-remitting multiple sclerosis (RRMS).
"The effectiveness of an experimental malaria vaccine developed by GlaxoSmithKline wanes over time, with the shot protecting only 16.8 percent of children over four years, according to trial data," Reuters reports.
› Verified 7 days ago
| Entity Name | Telegraph Urgent Care Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992190243 PECOS PAC ID: 9830400472 Enrollment ID: O20150623001722 |
News Archive
Designed with the complete workflow in mind, Olympus has launched its cellVivo incubation system, for precise and ergonomic environmental control of advanced live cell imaging. Following the modular approach of the IX3 range of inverted microscope frames, cellVivo is based on a "one size fits all" concept, with adaptors for various IX73 and IX83 frame types, circumventing the need for multiple incubation systems for distinct microscope configurations.
Researchers from Texas A&M University, led by Dr. Akhilesh K. Gaharwar, have developed a new way to deliver treatment for cartilage regeneration.
Dune Medical Devices, Inc. today announced that the landmark, 664-patient pivotal trial evaluating the MarginProbe System met its primary endpoints. The MarginProbe System provides surgeons with a real time, intraoperative technology to detect microscopically-positive margins on excised tissues.
Laquinimod is an orally available synthetic compound that has been successfully evaluated in phase II/III clinical studies for the treatment of relapsing-remitting multiple sclerosis (RRMS).
"The effectiveness of an experimental malaria vaccine developed by GlaxoSmithKline wanes over time, with the shot protecting only 16.8 percent of children over four years, according to trial data," Reuters reports.
› Verified 7 days ago
| Entity Name | Independent Hospitalist Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851820641 PECOS PAC ID: 3971874090 Enrollment ID: O20170808003906 |
News Archive
Designed with the complete workflow in mind, Olympus has launched its cellVivo incubation system, for precise and ergonomic environmental control of advanced live cell imaging. Following the modular approach of the IX3 range of inverted microscope frames, cellVivo is based on a "one size fits all" concept, with adaptors for various IX73 and IX83 frame types, circumventing the need for multiple incubation systems for distinct microscope configurations.
Researchers from Texas A&M University, led by Dr. Akhilesh K. Gaharwar, have developed a new way to deliver treatment for cartilage regeneration.
Dune Medical Devices, Inc. today announced that the landmark, 664-patient pivotal trial evaluating the MarginProbe System met its primary endpoints. The MarginProbe System provides surgeons with a real time, intraoperative technology to detect microscopically-positive margins on excised tissues.
Laquinimod is an orally available synthetic compound that has been successfully evaluated in phase II/III clinical studies for the treatment of relapsing-remitting multiple sclerosis (RRMS).
"The effectiveness of an experimental malaria vaccine developed by GlaxoSmithKline wanes over time, with the shot protecting only 16.8 percent of children over four years, according to trial data," Reuters reports.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vesna Tegeltija, MD 1101 W University Dr, 3-north, Rochester, MI 48307-1863 Ph: (248) 601-4805 | Vesna Tegeltija, MD 1101 W University Dr, 3-north, Rochester, MI 48307-1863 Ph: (248) 601-4805 |
News Archive
Designed with the complete workflow in mind, Olympus has launched its cellVivo incubation system, for precise and ergonomic environmental control of advanced live cell imaging. Following the modular approach of the IX3 range of inverted microscope frames, cellVivo is based on a "one size fits all" concept, with adaptors for various IX73 and IX83 frame types, circumventing the need for multiple incubation systems for distinct microscope configurations.
Researchers from Texas A&M University, led by Dr. Akhilesh K. Gaharwar, have developed a new way to deliver treatment for cartilage regeneration.
Dune Medical Devices, Inc. today announced that the landmark, 664-patient pivotal trial evaluating the MarginProbe System met its primary endpoints. The MarginProbe System provides surgeons with a real time, intraoperative technology to detect microscopically-positive margins on excised tissues.
Laquinimod is an orally available synthetic compound that has been successfully evaluated in phase II/III clinical studies for the treatment of relapsing-remitting multiple sclerosis (RRMS).
"The effectiveness of an experimental malaria vaccine developed by GlaxoSmithKline wanes over time, with the shot protecting only 16.8 percent of children over four years, according to trial data," Reuters reports.
› Verified 7 days ago
Dr. Anil Singh, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1101 W University Dr, Rochester, MI 48307 Phone: 734-464-0887 Fax: 734-402-0254 | |
Dr. Kewal K Aggarwal, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 W University Dr, Rochester, MI 48307 Phone: 248-651-8200 Fax: 248-651-9546 | |
Dr. Delfin Santos, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 135 Barclay Circle, Suite 100, Rochester, MI 48307 Phone: 248-852-2277 Fax: 248-852-2552 | |
Noor Naji, Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1101 W University Dr # 3-north, Rochester, MI 48307 Phone: 248-601-4805 | |
Daniel Kapadia, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1101 W University Dr, Rochester, MI 48307 Phone: 734-377-4040 | |
Dr. Gina L Buccalo, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1135 W University Dr Ste 225, Rochester, MI 48307 Phone: 248-824-2570 Fax: 248-824-2571 | |
Frank Sottile, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1101 W University Dr, Rochester, MI 48307 Phone: 248-652-5000 |